Dr. Reichel is available for appointments in Boston, and Leominster.

Elias Reichel, MD

Vice Chair for Research and Education,
Department of Ophthalmology

Director, Vitreoretinal Diseases and Surgery Service

Director, Medical Retina Fellowship


Dr. Reichel's areas of expertise include both medical and surgical retinal disorders. His surgical interests include surgery for macular disorders, retinal detachment, and trauma of the posterior segment. He has a special interest in hereditary retinal degenerations, macular degeneration, and diabetic retinopathy.

Research Interests: Dr. Reichel has a special research interest in macular degeneration, hereditary retinal degenerations, and diabetic retinopathy.  He is the principal investigator for several clinical trials evaluating experimental treatments for retinal disorders.  Dr. Reichel has developed lenses for visualizing laser treatments, vitrectomy lens systems and a topical anesthetic for ocular procedures. 


Dr. Reichel's Office: 617-636-1648

Fax: 617-636-4866

Patient Appointments: Boston: 617-636-4600
Leominster: 978-534-6100



Vitreoretinal Diseases and Surgery, New England Eye Center

Electrophysiology and Molecular Genetics, Massachusetts Eye and Ear Infirmary

Genetics, Children's Hospital, Boston


Massachusetts Eye and Ear Infirmary

Medical School

Albert Einstein College of Medicine

Academic Appointment

Professor of Ophthalmology, Tufts University School of Medicine

Board Certification

American Board of Ophthalmology

Professional Honors and Awards

       2009 – Senior Honor Award, American Academy of Ophthalmology
       2009 – Best Doctors in America

Personal Interests

In addition to Dr. Reichel’s active clinical and research work at New England Eye Center, he has several entrepreneurial endeavors:

  • Developer of Transpupillary Thermotherapy for Choroidal Neovascularizaton.
  • Developer of 3.5% lidocaine gel for ocular anesthesia – FDA approved 2008.
  • Founder of Hemera Biosciences – developing a gene therapy for dry age-related macular degeneration entering phase 1 March, 2017.
  • Dr. Reichel also serves on the Editorial Board of Retina Today, and is an  Editor of Clinical Therapeutics.

Academic Affiliations/Memberships

1985 – Alpha Omega Alpha
1987 – Association for Research in Vision and Ophthalmology
1991 – FOVEA Fluorescein Angiography Club
1992 – Massachusetts Eye and Ear Infirmary, Alumni Association
1993 – American Academy of Ophthalmology
1994 – Massachusetts Medical Society
1994 – Massachusetts Society of Eye Physicians and Surgeons
1995 – American Society of Retina Specialists
1995 – Macula Society        
2001 – Retina Society
2013 – AAO  Research, Regulatory, and External Scientific Affairs Committee


Foreign languages spoken


Selected Publications

Dryja TP, McGee TL, Reichel E, Hahn LB, Crowley GS, Yandell DW, Sandberg MA, Berson EL.  A Point Mutation of the Rhodopsin Gene in One Form of Retinitis Pigmentosa.  Nature. 1990; 343:364-366.

Reichel E, Berrocal AM, Ip M, Kroll AJ, Desai V, Duker JS, Puliafito CA.  Transpupillary Thermotherapy (TTT) of Occult Subfoveal Choroidal Neovascularization in Patients with Age-Related Macular Degeneration.  Ophthalmology.  1999;106:1908-1914.

Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E.   Intravitreal triamcinolone acetonide for macular edema due to central retinal vein occlusion.  Br J Ophthalmol. 2002; 86(2):247-8.

Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C.  Intravitreal triamcinolone for refractory diabetic macular edema.  Ophthalmology.  2002;109(5):920-7.

Mainster MA, Reichel E,  Harrington PG.  A wide-field, high-resolution ophthalmoscopic contact lens.  Ophthalmic Surg Lasers Imaging. 2003;34:76-7.

Busbee BG, Alam A, Reichel E.  Lidocaine Hydrochloride Gel for Ocular Anesthesia Results of a Prospective, Randomized Study.  Ophthalmic Surg Lasers Imaging 2008;39:386-390.

Goldberg RA, Reichel E, Oshry LJ. Bilateral toxoplasmosis retinitis associated with ruxolitnib. New  Engl J Med. 2013 Aug 15;369-3.



Elias Reichel